Alpha Tau Medical Ltd(DRTS)

Biotechnology · Jerusalem, JM

$14.64-0.25 (-1.68%)

Delayed quote: Oct 6, 2026, 12:00 PM EDT

EV/EBITDA Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBITDA ratio is N/A as of 2026-10-06T16:02:25.022Z.

Stored calculation inputs

Calculation as of: 2026-10-06T16:02:25.022Z.

Quote observation: 2026-10-06T16:00:11.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 1,322,370,825
Total debt · period ending 2026-06-30: 15,152,000
Cash · period ending 2026-06-30: 22,993,000
TTM operating EBITDA · period ending 2026-06-30: N/A

FMP input reference: d0cade57d6bc8828dc71ac364ddc44a4328d7c948fb2699a56d4eea8e3f6e5b7

EV/Sales|P/E Ratio|EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

DRTS EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

N/A

DRTS Competitors' EV/EBITDA Ratio

DRTS

Alpha Tau Medical Ltd

Current

Market Cap

$1.32B

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

OMER

Omeros Corporation

vs DRTS

Market Cap

$1.35B

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

COAG

Hemab Therapeutics Holdings, Inc. Common Stock

vs DRTS

Market Cap

$1.37B

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

KARD

Kardigan, Inc.

vs DRTS

Market Cap

$1.27B

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ORIC

ORIC Pharmaceuticals, Inc.

vs DRTS

Market Cap

$1.24B

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

INBX

Inhibrx Biosciences Inc.

vs DRTS

Market Cap

$1.41B

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

KLRA

Kailera Therapeutics, Inc.

vs DRTS

Market Cap

$1.41B

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

OMDA

Omada Health

vs DRTS

Market Cap

$1.23B

EV/EBITDA Ratio

145.43x

TTM Avg

171.92x

3Y Avg

171.92x

5Y Avg

171.92x

PNTG

The Pennant Group, Inc.

vs DRTS

Market Cap

$1.42B

EV/EBITDA Ratio

25.73x

TTM Avg

25.42x

3Y Avg

27.51x

5Y Avg

46.70x

CRON

Cronos Group Inc.

vs DRTS

Market Cap

$1.23B

EV/EBITDA Ratio

28.08x

TTM Avg

20.27x

3Y Avg

20.27x

5Y Avg

20.27x

NAME	MARKET CAP	EV/EBITDA RATIO	TTM	3Y	5Y
Alpha Tau Medical Ltd (DRTS)	$1.32B	N/A	N/A	N/A	N/A
Omeros Corporation (OMER)vs ›	$1.35B	N/A	N/A	N/A	N/A
Hemab Therapeutics Holdings, Inc. Common Stock (COAG)vs ›	$1.37B	N/A	N/A	N/A	N/A
Kardigan, Inc. (KARD)vs ›	$1.27B	N/A	N/A	N/A	N/A
ORIC Pharmaceuticals, Inc. (ORIC)vs ›	$1.24B	N/A	N/A	N/A	N/A
Inhibrx Biosciences Inc. (INBX)vs ›	$1.41B	N/A	N/A	N/A	N/A
Kailera Therapeutics, Inc. (KLRA)vs ›	$1.41B	N/A	N/A	N/A	N/A
Omada Health (OMDA)vs ›	$1.23B	145.43x	171.92x	171.92x	171.92x
The Pennant Group, Inc. (PNTG)vs ›	$1.42B	25.73x	25.42x	27.51x	46.70x
Cronos Group Inc. (CRON)vs ›	$1.23B	28.08x	20.27x	20.27x	20.27x

EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

EV/Sales P/E Ratio EBITDA All Metrics